Role of gokshura-madhuyasti-ksheerpaka and ashvagandha-ksheerpaka in menstrual disorders.

A comparative clinical study of goká¹£ura- madhuyaá¹£á¹i-ká¹£Ä«rapÄ?ka and aÅ?vagandhÄ?-ká¹£Ä«rapÄ?ka in vÄ?tikaÄ?rtavaduá¹£á¹i in the purview of â??yogÄ?nÄ?á¹? rasÄ?yanavÄ?jÄ«karaá¹?amÅ«tradoá¹£apratiá¹£edhoktÄ?nÄ?mavacÄ?raá¹?amâ??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052221

Enrollment

Registered

2023-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients complaining any of following manifestation a) Ä?rtava vaivará¹?ya (Discolored Menstrual Blood) - Aruá¹?a vará¹?a (Red/Reddish Brown/Tawny) or Å?yÄ?va vará¹?a (Dark Brown) or ká¹?á¹£á¹?a vará¹?a (Black). b) Alpa Ä?rtava (Hypomenorrhoea) c) Vicchinna Ä?rtava (Interrupted bleeding) d) SarujÄ? Ä?rtava (Painful Menses) e) CirÄ?t niá¹£icyate (Oligomenorrhoea). 2. Female patients of age group 12 â?? 45 years. 3. Hb% >= 8 gm/dl.

Exclusion criteria

Exclusion criteria: 1. Patient with any pelvic pathology. 2. Patient with thyroid hormone abnormality. 3. Patient with any systemic or psychiatric illness. 4. Patient using oral contraceptive pills and Intra Uterine Contraceptive Devices. 5. Patient having Sexually Transmitted Diseases.

Design outcomes

Primary

Measure	Time frame
Effect on symptoms of vÄ?tika Ä?rtavaduá¹£á¹i.Timepoint: 8 weeks or 2 consecutive menstrual cycles	—

Secondary

Measure	Time frame
Change in quality of life.Timepoint: 60 days or 2 consecutive cycles	—

Countries

India

Contacts

Public ContactDr Garima Bhamu

National Institute of Ayurveda

guptadr.nisha@gmail.com9828087640

Outcome results